Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study
详细信息    查看全文
文摘
class="listitem" id="list_ulist0010">
class="label">•

Germany-wide personalised medicine study for high-risk paediatric cancer patients.

class="label">•

Comprehensive sequencing and analysis is feasible in clinically relevant time frame.

class="label">•

Half of patients across entities harbored a reasonable confidence druggable target.

class="label">•

Cases of clinical response to targeted agents demonstrate proof of principle.

class="label">•

This model can expand paediatric access to molecular profiling and targeted therapies.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700